

Boiron is a Homeopathy company and has developed an app for iOS users Om_om_mo. Among its major competitors, Boiron is ranked in 2nd place for NPS while Weleda is 1st, and Alnylam Pharmaceuticals is 3rd.
Boiron's Net Promoter Score (NPS) is a 100 with 100% Promoters, 0% Passives, and 0% Detractors. Net Promoter Score tracks whether Boiron's customers would recommend using the product based on a scale of -100 to 100.
| 100% | Promoters |
|---|---|
| 0% | Passives |
| 0% | Detractors |
| Summary | Date | Score |
|---|---|---|
Oct 2023 100 | Oct 2023 | 100 |
Boiron is ranked first for NPS among its competitors. Alnylam Pharmaceuticals and AbbVie come in second and third, with Sanofi coming in at #4.
![]() Boiron | ![]() AbbVie | ![]() Sanofi | ![]() Alnylam Pharmaceuticals | |
| Global Ranking | #- | #321 | #- | #- |
| NPS | 100 | 22 | 20 | 40 |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | Neutral | Neutral |
| Valuation Updated every 24 hours for public companies | - | $190.99B | $129.27B | $24.72B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Boiron's NPS is rated right above Alnylam Pharmaceuticals, and is preceded by Weleda.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Weleda | 100 |
![]() | Boiron | 100 |
![]() | Alnylam Pharmaceuticals | 40 |
![]() | bioMerieux | 39 |
![]() | AbbVie | 22 |
![]() | Sanofi | 20 |
![]() | Boehringer Ingelheim Pharmaceuticals | N/A |